Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease
Authors:
Open Access
- 1 January 2016
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 275, 220-231
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labor, and Welfare of Japan
This publication has 45 references indexed in Scilit:
- Neuropathic Pain in Rats with a Partial Sciatic Nerve Ligation Is Alleviated by Intravenous Injection of Monoclonal Antibody to High Mobility Group Box-1PLOS ONE, 2013
- Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson’s DiseaseMediators of Inflammation, 2013
- High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblastsArthritis Research & Therapy, 2011
- Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood–Brain Barrier From Ischemia-Induced Disruption in RatsStroke, 2011
- Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissueNeuroscience, 2011
- CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's diseaseJournal of Neuroinflammation, 2011
- Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in SynucleinopathiesJournal of Biological Chemistry, 2010
- Microglial Physiology: Unique Stimuli, Specialized ResponsesAnnual Review of Immunology, 2009
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993